Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Mounjaro a day early — shifting your injection from day seven to day six — is unlikely to cause harm for most people, but it does shift your entire weekly schedule going forward. Mounjaro (tirzepatide) is designed as a once-weekly injection, and the seven-day interval exists because that is how long the medicine stays active in your body. Moving an occasional dose forward by one day is generally considered a minor timing variation; doing it repeatedly can make the interval unpredictable, which may affect how consistently the medicine works. These are prescription-only medicines, and any planned change to your injection schedule should be discussed with your prescriber rather than decided alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, usually from someone who has a holiday, a medical procedure, or a busy weekend coming up and wants to know whether moving their injection forward by 24 hours will cause a problem.
The short answer: a single day early is unlikely to cause serious harm. Tirzepatide has a half-life of roughly five days, which means a meaningful amount of the previous dose is still circulating when the next one is due. Bringing that interval from seven days to six compresses it slightly, but not dramatically. You may notice slightly more of the usual side effects (nausea, fullness, or digestive changes) in the day or two after injecting, because the two doses overlap a little more than usual.
What matters more is what you do next. If you inject early this week, your new 'day one' resets from that earlier date. Keeping the subsequent injections seven days from there is important. If you find yourself wanting to read about whether it is safe to inject a day early as a regular strategy rather than an occasional workaround, that conversation belongs with your prescriber. The NHS tirzepatide guidance is consistent on this point: stick to the weekly schedule as closely as you can.
Yes, meaningfully so. One day is a minor compression; two days is a larger one, and the risk-benefit calculation changes. At a six-day interval the overlap is small. At a five-day interval there is noticeably more of the previous dose still present, and the likelihood of amplified gastrointestinal effects goes up. At four days or fewer, you are compressing the schedule significantly.
The practical concern is not that a single compressed dose will derail your treatment. It is that a compressed dose can make nausea, vomiting or diarrhoea more pronounced, and if that puts you off continuing or leads you to delay future doses, it creates a different kind of disruption. For more detail on the specific considerations around a larger time shift, taking Mounjaro two days early is covered separately.
The Mounjaro Patient Information Leaflet and the summary of product characteristics (both available via the electronic Medicines Compendium) are the authoritative references for dosing windows. If you are unsure, read those first or contact your prescriber before making any change.
A little extra nausea or a reduced appetite after an early injection fits with what you would expect: a slightly elevated combined effect from the two overlapping doses. For most people this settles within a day or two as the body processes the medicine.
The steps that help are the same ones that apply at any dose level: small, protein-rich meals, staying well hydrated, avoiding fatty or very rich food, and not lying down immediately after eating. These are described in more detail on how Mounjaro works after each injection.
Where you should seek medical attention promptly is if you develop severe, persistent stomach pain, particularly pain that radiates through to your back, with or without vomiting. The MHRA issued specific guidance in January 2026 highlighting acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines; that symptom profile is the key warning sign. If you experience it, contact a doctor or call NHS 111 the same day. Do not wait to see if it passes.
Yes. Mounjaro does not need to be taken on the same day of the week forever. If you started on Mondays and life has shifted to make Thursdays more practical, you can move your day. The way to do it without compressing the interval by more than one day is to take two or three consecutive doses slightly earlier or later, nudging the schedule across. For the specific steps involved in moving forward by a single day, the guidance on injecting a day early covers the mechanics.
If you need to move in the other direction, taking Mounjaro a day late follows a similar logic. The Patient Information Leaflet also covers what to do if you miss a dose entirely, that is different from taking it early, and the approach differs too.
Storage is a separate consideration worth flagging: if you are injecting early partly because you are about to travel, check how long your pen can safely stay outside the fridge. Mounjaro's room-temperature window is governed by the SmPC, and the exact figure matters. Understanding the full picture of how the Mounjaro injection works can also help you feel more confident about these practical decisions. If you have ongoing questions about your schedule, our prescribers are here, you can start a free consultation or reach us through the contact page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.